AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
42 hedge funds and large institutions have $789M invested in Ambrx Biopharma, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 6 closing their positions.
Holders
42
Holders Change
+12
Holders Change %
+40%
% of All Funds
0.66%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
13
Reduced
8
Closed
6
Calls
$4.87M
Puts
$3.92M
Net Calls
+$949K
Net Calls Change
-$9.86M